Drugs for the Treatment of Respiratory Diseases
Drugs for the Treatment of Respiratory Diseases
Clive P. Page, King's College London
William J. Metzger, National Jewish Medical and Research Centre, Denver
Brian J. O'Connor, King's College London
$414.00
USDMillions of people are affected by these diseases, and the re-emergence of tuberculosis and increase in asthma in certain populations underline the importance of finding effective treatments. The demographice make this a critical time to identify novel strategies to prevent and treat these increasingly common diseases. The volume surveys and evaluates the drug treatments available for the main categories of lung diseases, including asthma, tuberculosis, smoking disorders, lung cancer, and respiratory infections.
- First comprehensive survey of established and novel drug treatments for all categories of respiratory diseases
- The re-emergence and increased prevalence of some of these diseases makes this publication more timely than ever
- An essential source of reference for all health professionals looking after patients with respiratory diseases
Reviews & endorsements
"...a welcome addition to any pulmonologist's reference library." Respiratory Care
"There are very few similar textbooks on this topic that provide this degree of depth and a current view of drug therapy of respiratory diseases...this is a very good text, most appropriate for sophisticated clinicians and researchers who seek to achieve great depth in their understanding of the basic and clinical pharmacology of drugs used in the treatment of respiratory diseases." Annals of Pharmacotherapy
"[T]his book is clearly written and produced and unusually well illustrated...extremely useful..." Pharmaceutical Journal
Product details
December 2004Adobe eBook Reader
9780511060472
0 pages
0kg
108 b/w illus. 15 colour illus. 57 tables
This ISBN is for an eBook version which is distributed on our behalf by a third party.
Table of Contents
- Part I. Asthma and COPD:
- 1. Pathology of asthma and COPD Peter K. Jeffery
- 2. Glucocorticosteroids Peter J. Barnes
- 3. ß2- adrenoceptor agonists Domenico Spina, Clive P. Page and Brian J. O'Connor
- 4. Anticholinergic bronchodilators Jeremy M. Segal and Nicholas J. Gross
- 5. Antiallergic drugs Mazakazu Ichinose
- 6. Drugs affecting the synthesis and action of leukotrienes Paul M. O'Byrne
- 7. Theophylline and selective phosphodiesterase inhibitors in the treatment of respiratory disease N. A. Jones, Domenico Spina and Clive P. Page
- 8. Potential therapeutic effects of potassium channel openers in respiratory diseases Ahmed Z. El-Hashim
- 9. Tachykinin and kinin antagonists Pierangelo Geppetti
- 10. Drugs affecting IgE (synthesis inhibitors and monoclonal antibodies) Lawrence G. Garland and Alan G. Lamont
- 11. Drugs targeting cell signalling Brydon L. Bennett, Yoshitaka Satoh and Alan J. Lewis
- Part II. Diffuse Parenchymal Lung Disease:
- 12. Current approaches to the treatment of parenchymal lung diseases Joseph P. Lynch III and Michael Keane
- 13. Drug treatments of the future in fibrotic lung disease Athol U. Wells
- Part III. Infection:
- 14. Current and future management of pneumonia Mario Cazzola and Maria G. Matera
- 15. Current treatment of chronic bronchial suppuration Robert Wilson
- 16. Current and future treatment of cystic fibrosis R. Gary, G. Ruiz, Hilary Wyatt and John F. Price
- Part IV. Pulmonary Vascular Diseases:
- 17. Pathophysiology of pulmonary vascular disease Sanjay Mehta and David G. McCormack
- 18. Current treatment of pulmonary vascular diseases Tarek Saba and Andrew Peacock
- 19. Future treatment of pulmonary vascular diseases Norbert F. Voelkel, M. W. Geraci and S. Abman
- Part V. Lung Cancer:20. Molecular pathology of lung cancer Ignacio I. Wistuba and Adi F. Gazdar
- 21. Small cell lung cancer Desmond N. Carney
- Part VI. Cough:
- 22. Mechanisms of cough John J. Adcock
- 23. Current treatment of cough Peter V. Dicpinigaitis.
